<DOC>
	<DOCNO>NCT00642551</DOCNO>
	<brief_summary>From K-vitamins , menaquinone-7 ( MK-7 ) identify effective cofactor carboxylation reaction Gla-proteins osteocalcin ( bone ) matrix-Gla protein ( arterial vessel wall ) . The question remain whether supplementation MK-7 also lead measurable improvement bone vascular health . The purpose study demonstrate MK-7 health benefit apparently healthy postmenopausal woman . In placebo-controlled randomized clinical trial effect MK-7- supplement monitor three year bone quantity quality vascular characteristic function .</brief_summary>
	<brief_title>Beneficial Effects Long Term Menaquinone-7</brief_title>
	<detailed_description />
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<criteria>Healthy postmenopausal woman 55 65 year old Subjects normal body weight height accord BMI &lt; 30 Subjects Caucasian race Subject give write consent take part study Subjects ( history ) metabolic gastrointestinal disease Subjects present chronic degenerative and/or inflammatory disease Subjects receive systemic treatment topical treatment likely interfere evaluation study parameter Subjects receive corticoÏŠd treatment Subjects use oral anticoagulant Subject use bisphosphonates Subjects use hormone replacement therapy Subjects undergoing ovariectomy and/or hysterectomy Subject ( history ) soy allergy Subjects use vitamin K contain multivitamin vitamin K supplement Subjects participate clinical study recently one month current study Subjects find osteoporotic baseline ( Tscore &lt; 2.5 )</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>vitamin K2</keyword>
	<keyword>menaquinone-7</keyword>
	<keyword>bone health</keyword>
	<keyword>vascular health</keyword>
</DOC>